. 2019 Aug 1;13:2633–2641. doi: 10.2147/DDDT.S211845

Table 2.

Effects of ondansetron and [6]-gingerol on body weight of cisplatin-treated rats

	( $\overset{ˉ}{\bi x}$ ±SE，g)
	−48 hrs	−24 hrs	0 hr	24 hrs
Con	239.57±5.94	247.08±6.17	253.17±6.23	262.08±5.77
O-con	239.48±5.80	247.48±6.34	254.25±7.08	264.93±6.09
G-con	237.23±4.96	243.97±5.46	251.17±5.88	262.65±6.02
Model	244.20±4.03	250.07±4.59	255.33±4.37	240.80±4.34^a
O-treated	240.35±3.68	247.47±4.32	253.03±4.79	239.72±3.54^a
G-treated	233.65±6.00	242.32±5.70	247.82±5.37	237.27±5.47^a

Notes: ^aP<0.05, compared with Con . Cisplatin (6 mg/kg (weight), i.p.) was administered at t=0.

Abbreviations: Con, the normal control group; O-Con, the rats treated with ondansetron; G-con, the rats treated with [6]-gingerol; Model, the rats injected intraperitoneally with cisplatin; O-treated, the ondansetron-treated model group; G-treated, the [6]-gingerol-treated model group.